Hematology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Podcasts Q&As
Interactive
Polls Quizzes
Events & Education
ASH Annual Meeting

Q&As

Expert Q&A
Dr Tang
Expert Q&A
How Will the ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Dr Tang
Expert Q&A
How Will the ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Dr Tang
Expert Q&A
How Will the ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Dr Tang
Expert Q&A
How Will the ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Dr Tang
Expert Q&A
How Will the ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
The Impact of Technology on the Management of Patients With Diabetes
02/14/2024
Rachel Stahl Salzman, MS, RDN, CDCES; Lisa Jones, MA, RDN, LDN, FAND
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
02/14/2024
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
The Impact of Technology on the Management of Patients With Diabetes
02/14/2024
Rachel Stahl Salzman, MS, RDN, CDCES; Lisa Jones, MA, RDN, LDN, FAND
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
02/14/2024
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
The Impact of Technology on the Management of Patients With Diabetes
02/14/2024
Rachel Stahl Salzman, MS, RDN, CDCES; Lisa Jones, MA, RDN, LDN, FAND
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
02/14/2024
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
The Impact of Technology on the Management of Patients With Diabetes
02/14/2024
Rachel Stahl Salzman, MS, RDN, CDCES; Lisa Jones, MA, RDN, LDN, FAND
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
02/14/2024
Expert Q&A
Rachel Stahl Salzman, MS, RDN, CDN, CDCES
Expert Q&A
The Impact of Technology on the Management of Patients With Diabetes
02/14/2024
Rachel Stahl Salzman, MS, RDN, CDCES; Lisa Jones, MA, RDN, LDN, FAND
Diabetes technology has improved significantly in recent years, including the use of blood glucose meters, continuous glucose monitors (CGM), cutting-edge insulin pumps, and more. Lisa Jones, MA, RDN, LND,...
02/14/2024